Two trials from the same research group sound like vulnerable relationship status updates
— Two trials from the same research group sound like vulnerable relationship status updates
by Kristina Fiore, Director of Enterprise & Investigative Reporting, MedPage Today
September 2, 2026
• 2 min read
Cardiology is going through it -- so say commenters on social media, at least.
A winner, a loser, and a mid-stage signal from a major cardiology research conference
ESC ‘26: Cytokinetics’ sell-off, Arrowhead’s edge and a heart drug autopsy
ESC: AZ, Ionis' Wainua post-mortem throws water on silencer-plus-stabilizer approach in ATTR-CM
European Society of Cardiology Congress
Healthcare social media content gathered by MedPage Today staff
The mental health system after Lindsay Clancy, pushing boundaries for new radiopharmaceuticals, and more health news from Morning…
Healthcare social media content gathered by MedPage Today staff
Recent developments of interest in cardiovascular medicine
Healthcare social media content gathered by MedPage Today staff
At a big meeting for cardiovascular medicines, Cytokinetics and Arrowhead aimed to separate their drugs from competitors while a…
